Idiopathic hypertrophic pachymeningitis: Does earlier treatment improve outcome?

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background/goal: Hypertrophic pachymeningitis is a rare chronic inflammatory disorder characterized by marked fibrous thickening of the cerebral and/or spinal dura mater. This condition has largely been reported in adults, but there are very few reports in children. Methods: We describe a 14-year-old boy with idiopathic hypertrophic pachymeningitis, who presented with deteriorating vision on a background of severe headache. We evaluated pediatric cases of hypertrophic pachymeningitis and compared treatments and their relation to outcomes. Results: There are only eleven pediatric cases of hypertrophic pachymeningitis reported in the literature. In the patients treated with steroids either at presentation or subsequent relapses, a good response was reported. In the cases with delayed initiation of steroid treatment, this was often related to an incomplete recovery. In our patient, this delay may have contributed to his poor visual outcome. Conclusions: Early initiation of steroid treatment in children with idiopathic hypertrophic pachymeningitis may improve outcomes.

Cite

CITATION STYLE

APA

Rizzo, E., Ritchie, A. E., Shivamurthy, V., Siddiqui, A., & Lim, M. (2021). Idiopathic hypertrophic pachymeningitis: Does earlier treatment improve outcome? Children, 8(1). https://doi.org/10.3390/children8010011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free